THE IMPORTANCE OF POSTMARKETING DRUG SURVEILLANCE

被引:0
|
作者
SMART, AJ
WALTERS, L
机构
来源
SOUTH AFRICAN MEDICAL JOURNAL | 1992年 / 82卷 / 06期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:383 / 384
页数:2
相关论文
共 50 条
  • [31] Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions
    Gex-Fabry, M
    Balant-Gorgia, AE
    Balant, LP
    [J]. DRUG SAFETY, 2001, 24 (13) : 947 - 959
  • [32] Therapeutic Drug Monitoring Databases for Postmarketing Surveillance of Drug-Drug Interactions
    Marianne Gex-Fabry
    Luc P. Balant
    Androniki E. Balant-Gorgia
    [J]. Drug Safety, 2001, 24 : 947 - 959
  • [34] US FDA Enhancing Postmarketing Drug Safety Surveillance
    不详
    [J]. PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 64 - 64
  • [35] POSTMARKETING DRUG SURVEILLANCE - DATA PRESENTATION AND ELEMENTS FOR A DECISION
    LAGIER, G
    [J]. REVUE DE MEDECINE INTERNE, 1986, : 41 - 44
  • [36] An Evaluation of Drug-Ineffective Postmarketing Reports in Drug Safety Surveillance
    Misu, Takashi
    Kortepeter, Cindy
    Munoz, Monica
    Wu, Eileen
    Chung, Haemy
    Dal Pan, Gerald J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 324 - 324
  • [37] POSTMARKETING SURVEILLANCE
    VOSS, S
    HARRIS, F
    [J]. BRITISH MEDICAL JOURNAL, 1994, 309 (6948): : 194 - 194
  • [38] POSTMARKETING SURVEILLANCE
    DENES, G
    [J]. MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1990, 132 (23): : 373 - 375
  • [39] A team agent approach to postmarketing surveillance of adverse drug reactions
    Ji, Yanqing
    Ying, Hao
    Barth-Jones, Daniel C.
    Yen, John
    Zhu, Shizhuo
    Miller, Richard E.
    Massanari, R. Michael
    [J]. 2005 27TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7, 2005, : 6969 - 6972
  • [40] POSTMARKETING DRUG SURVEILLANCE - HOW FAR HAVE WE GOT
    MCDEVITT, DG
    MACDONALD, TM
    [J]. QUARTERLY JOURNAL OF MEDICINE, 1991, 78 (285): : 1 - 3